A perspective on 99mTc and 125/131I labeled receptor targeted compounds and their in vitro/in vivo affinities
| Autor: | F. Zumrut Biber Muftuler, Perihan Ünak |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.drug_class
Health Toxicology and Mutagenesis Estrogen receptor Peptide Pharmacology 010403 inorganic & nuclear chemistry 01 natural sciences Analytical Chemistry 03 medical and health sciences 0302 clinical medicine In vivo Opioid receptor medicine Radiology Nuclear Medicine and imaging Receptor Spectroscopy chemistry.chemical_classification Public Health Environmental and Occupational Health Cancer medicine.disease Pollution Affinities In vitro 0104 chemical sciences Nuclear Energy and Engineering chemistry 030220 oncology & carcinogenesis |
| Zdroj: | Journal of Radioanalytical and Nuclear Chemistry. 314:1-6 |
| ISSN: | 1588-2780 0236-5731 |
| DOI: | 10.1007/s10967-017-5353-4 |
| Popis: | A large number of radiolabeled compounds have been studied to identify their potential as diagnostic and therapeutic tools in different cancer types. We reviewed several of our studies to give a perspective on 99mTc and 125/131I labeled receptor targeted compounds which are estrogen receptor targeted, anti estrogen receptor targeted, opioid receptor targeted and receptor-binding peptide and their bioaffinities by using in vitro/in vivo methods. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|